17 Oct 2024Open access
Author Correction: ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19Publisher siteScientific Reports, Diverse Scientific Research Studies
Active, last published 2026
Zeynab
Fakhar
Scholar“Research profile drawn from open scholarly records.”
University of the Witwatersrand
South Africa1
H-index
1
Citations
Zeynab has not officially claimed their profile. If you are Zeynab, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Zeynab Fakhar will appear here once their profile is updated.
02 · Reach
Publication output and reach
Zeynab's work has been cited 1 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchUniversity of the Witwatersrand, South AfricaDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works18 Jan 2024Open access1cites
Revealing key structural features for developing new agonists targeting δ opioid receptor: Combined machine learning and molecular modeling perspectivePublisher siteMedicine in Drug Discovery, Computational Drug Discovery Methods
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Zeynab?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you